Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 


MARS Bioimaging to Position Itself for Series A Fundraising

February 25, 2014

MARS Bioimaging Raises over $500,000 to Position Itself for Series A Fundraising

Christchurch, February 25, 2014 — MARS Bioimaging raises more than NZ$500,000 in a capital financing led by Powerhouse Ventures (powerHouse).

MARS Bioimaging (MBI) intends to utilise the investment to strengthen the management and development teams prior to Series A fundraising later in 2014.

Originally spun out from the University of Canterbury in 2007, MBI is now releasing its first commercial grade xray scanners after successfully validating the groundbreaking technology with high profile medical research institutes.

The Director of Research & Innovation at the University of Canterbury, Dr Nigel Johnson, said “It is exciting to see worldleading physics and biomedical research culminating in a sophisticated medical instrument. This additional capital will help MBI’s machines contribute to health improvements globally while delivering economic benefits to New Zealand.”

MBI provides in vivo colour xray imaging, using spectral computed tomography (CT) technology developed by the CERNbased Medipix3 Collaboration and University of Canterbury researchers. University of Otago, Christchurch is a key partner.

Spectral CT can provide images of bone, soft tissue, calcifications and injected contrast agents. This decomposition ability has many advantages for detection, diagnosis and treatment of major diseases such as cancer and heart diseases.

MBI CEO, Professor Phil Butler, notes “MBI’s objective is to become the preclinical imaging company of choice for research organisations and drug development companies, and a key component supplier to the clinical human imaging market.”

The preclinical imaging market is estimated at US$1.7 billion and the human imaging market at US$28 billion.

MARS Bioimaging won the Canterbury Regional Deloitte Fast 50 Rising Star award in 2013.

powerHouse’s Managing Partner Stephen Hampson, said “We are delighted to announce the successful capital raise that will allow MBI to accelerate its entry into this exciting high growth sector.”

powerHouse develops intellectual property based businesses from innovations sourced mainly from its university partners and research institutes. powerHouse offers more than traditional seed and startup capital, with ongoing access to business incubation, HR recruitment and networks.

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Onetai Station: Overseas Investment Office Puts Ceol & Muir On Notice

The Overseas Investment Office (OIO) has issued a formal warning to Ceol & Muir and its owners, Argentinian brothers Rafael and Federico Grozovsky, for failing to provide complete and accurate information when they applied to buy Onetai Station in 2013. More>>

ALSO:

Tomorrow, The UN: Feds President Takes Reins At World Farming Body

Federated Farmers president Dr William Rolleston has been appointed acting president of the World Farmers’ Organisation (WFO) at a meeting in Geneva overnight. More>>

ALSO:

I Sing The Highway Electric: Charge Net NZ To Connect New Zealand

BMW is turning Middle Earth electric after today announcing a substantial contribution to the charging network Charge Net NZ. This landmark partnership will enable Kiwis to drive their electric vehicles (EVs) right across New Zealand through the installation of a fast charging highway stretching from Kaitaia to Invercargill. More>>

ALSO:

Watch This Space: Mahia Rocket Lab Launch Site Officially Opened

Economic Development Minster Steven Joyce today opened New Zealand’s first orbital launch site, Rocket Lab Launch Complex 1, on the Mahia Peninsula on the North Island’s east coast. More>>

Earlier:

Marketing Rocks!
Ig Nobel Award Winners Assess The Personality Of Rocks

A Massey University marketing lecturer has received the 2016 Ig Nobel Prize for economics for a research project that asked university students to describe the “brand personalities” of three rocks. More>>

ALSO:

Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>

ALSO:

Get More From Scoop

 
 
 
 
 
 
 
 
 
Business
Search Scoop  
 
 
Powered by Vodafone
NZ independent news